Spyglass Pharma Inc (SGP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,666,000 | 4,767,000 | 4,984,000 | 4,218,000 | 3,521,000 |
| Marketable Securities | 3,267,000 | 818,000 | 851,000 | 587,000 | 481,000 |
| Receivables | 1,804,000 | 1,479,000 | 1,407,000 | 1,329,000 | 1,808,000 |
| Inventories | 1,676,000 | 1,605,000 | 1,580,000 | 1,651,000 | 1,300,000 |
| Income taxes - deferred | 266,000 | 294,000 | 309,000 | 575,000 | 625,000 |
| TOTAL | $10,423,000 | $9,732,000 | $10,003,000 | $9,250,000 | $8,272,000 |
| Non-Current Assets | |||||
| PPE Net | 4,365,000 | 4,487,000 | 4,593,000 | 4,527,000 | 4,236,000 |
| Intangibles | 492,000 | 569,000 | 580,000 | 619,000 | 661,000 |
| Other Non-Current Assets | 791,000 | 681,000 | 735,000 | 875,000 | 967,000 |
| TOTAL | $5,648,000 | $5,737,000 | $5,908,000 | $6,021,000 | $5,864,000 |
| Total Assets | $16,071,000 | $15,469,000 | $15,911,000 | $15,271,000 | $14,136,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 242,000 | 1,278,000 | 1,569,000 | 1,023,000 | 1,423,000 |
| Accounts payable and accrued liabilities | 1,254,000 | 1,078,000 | 978,000 | 1,030,000 | 1,063,000 |
| Accrued Expenses | 794,000 | 632,000 | 443,000 | 315,000 | 429,000 |
| TOTAL | $4,162,000 | $4,659,000 | $5,166,000 | $4,805,000 | $4,729,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,414,000 | 2,399,000 | 2,392,000 | 2,410,000 | 21,000 |
| Other Non-Current Liabilities | 1,465,000 | 907,000 | 686,000 | 512,000 | 886,000 |
| TOTAL | $4,001,000 | $3,423,000 | $3,189,000 | $3,129,000 | $1,265,000 |
| Total Liabilities | $8,163,000 | $8,082,000 | $8,355,000 | $7,934,000 | $5,994,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,487,744 | 1,479,476 | 1,474,973 | 1,471,196 | 1,468,541 |
| Common Shares | 1,017,000 | 1,015,000 | 1,015,000 | 1,015,000 | 1,015,000 |
| Retained earnings | 10,119,000 | 9,472,000 | 9,613,000 | 10,918,000 | 11,840,000 |
| Other shareholders' equity | 566,000 | 922,000 | 1,138,000 | -426,000 | -477,000 |
| TOTAL | $7,908,000 | $7,387,000 | $7,556,000 | $7,337,000 | $8,142,000 |
| Total Liabilities And Equity | $16,071,000 | $15,469,000 | $15,911,000 | $15,271,000 | $14,136,000 |